Tackling Antimicrobial Resistance in the Shadow of COVID-19
ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic is a challenge for ongoing efforts to combat antimicrobial-resistant (AMR) bacterial infections. As we learn more about COVID-19 disease and drug stewardship evolves, there is likely to be a lasting impact of increased use of antimicrobial ag...
Enregistré dans:
Auteur principal: | |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9c0e4ad18c7e4a4b8de72f9e8b15fcad |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Soyez le premier à ajouter un commentaire!